Takeda Pharmaceutical Company Limited
4502・Prime Market・Pharmaceuticals
Takeda Pharmaceutical Company Limited4502
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-07-09 | Other | Corporate Governance Report 2026/07/09 |
| 2026-07-09 | Other | コーポレート・ガバナンスに関する報告書 2026/07/09 |
| 2026-07-08 | Other | 国外の当社グループ従業員に対する長期インセンティブ報酬制度に基づく新株式発行および自己株式処分の払込完了および一部失権に関するお知らせ |
| 2026-07-08 | Other | Takeda Completed Issuance of New Shares and Disposal of Treasury Shares under the LTIP for Employees Outside of Japan with Partial Forfeiture |
| 2026-06-29 | Other | Articles of Incorporation 2026/06/29 |
| 2026-06-29 | Other | 定款 2026/06/29 |
| 2026-06-25 | Other | 2026 ANNUAL INTEGRATED REPORT |
| 2026-06-25 | Other | 2026年統合報告書 |
| 2026-06-24 | Other | 取締役分掌等の決定およびジュリー・キムの代表取締役 社長CEO就任について |
| 2026-06-24 | Other | Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO |